A well-known cell cycle regulator, p27KIP1, and protein kinase CK2-α´ mediate pathologic growth of cardiomyocytes. The findings have potential implications for the development of new treatment approaches to cardiac hypertrophy (pages 315–324).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hauck, L. et al. Nat. Med. 14, 315–324 (2008).
Polyak, K. et al. Genes Dev. 8, 9–22 (1994).
Sherr, C.J. & Roberts, J.M. Genes Dev. 13, 1501–1512 (1999).
Kaldis, P. Cell 128, 241–244 (2007).
Poolman, R.A., Li, J.-M., Durand, B. & Brooks, G. Circ. Res. 85, 117–127 (1999).
Li, J.-M. & Brooks, G. Am. J. Physiol. 273, H1358–H1367 (1997).
Pasumarthi, K.B.S. & Field, L.J. Circ. Res. 90, 1044–1054 (2002).
Litchfield, D.W. Biochem. J. 369, 1–15 (2003).
Burton, P.B.J., Yacoub, M.H. & Barton, P.J.R. Eur. Heart J. 20, 604–611 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Force, T. The weakness of a big heart. Nat Med 14, 244–245 (2008). https://doi.org/10.1038/nm0308-244
Issue Date:
DOI: https://doi.org/10.1038/nm0308-244